<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cytogenetic and bone marrow culture studies were performed sequentially in 13 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) who responded to low dose <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> (Ara-C) treatment (complete in nine and partial in four patients) </plain></SENT>
<SENT sid="1" pm="."><plain>Of nine patients with initial clonal karyotypic abnormalities, six recovered a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype after attaining a response to treatment, but the other three patients retained partial or total karyotypic abnormalities </plain></SENT>
<SENT sid="2" pm="."><plain>A new clonal karyotypic abnormality appeared after treatment in one patient </plain></SENT>
<SENT sid="3" pm="."><plain>Eight patients showed <z:mpath ids='MPATH_458'>normal</z:mpath> colony growth of both granulocyte-macrophage colony-forming units and erythroid burst-forming units after treatment, but five were still defective </plain></SENT>
<SENT sid="4" pm="."><plain>There was a clear difference in the duration of response to treatment between these two groups </plain></SENT>
<SENT sid="5" pm="."><plain>Consolidation treatment was not effective in patients with persistent karyotypic abnormalities or defective colony formation </plain></SENT>
<SENT sid="6" pm="."><plain>Although the number of patients studied is small, these results suggest that hemopoiesis in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> following a response to treatment with low dose Ara-C is <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Consolidation chemotherapy is recommended to ensure and prolong the response in patients showing normalization of both cytogenetic and bone marrow culture results </plain></SENT>
</text></document>